Covered recipient · General Payments record
ILYAS A SHAIKH
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$6,352.81
- Reported across 316 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $643.47 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $241.32 | 17 |
| SK Life Science, Inc. | $189.62 | 6 |
| BOSTON SCIENTIFIC CORPORATION | $57.99 | 1 |
| Sumitomo Pharma America, Inc. | $54.51 | 2 |
| EISAI INC. | $52.58 | 2 |
| Abbott Laboratories | $29.86 | 1 |
| Teva Pharmaceuticals USA, Inc. | $17.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $29.86 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124800070 | CMS |
| ABBVIE INC. | $11.08 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070092 | CMS |
| ABBVIE INC. | $14.06 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070094 | CMS |
| ABBVIE INC. | $7.85 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070097 | CMS |
| ABBVIE INC. | $25.18 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070099 | CMS |
| ABBVIE INC. | $3.46 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070101 | CMS |
| ABBVIE INC. | $10.23 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070103 | CMS |
| ABBVIE INC. | $21.23 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070105 | CMS |
| ABBVIE INC. | $6.10 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070107 | CMS |
| ABBVIE INC. | $18.51 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070109 | CMS |
| ABBVIE INC. | $24.03 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070111 | CMS |
| ABBVIE INC. | $5.29 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070113 | CMS |
| ABBVIE INC. | $14.25 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070115 | CMS |
| ABBVIE INC. | $19.11 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070117 | CMS |
| ABBVIE INC. | $11.48 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070119 | CMS |
| ABBVIE INC. | $26.37 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070121 | CMS |
| ABBVIE INC. | $18.27 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070123 | CMS |
| ABBVIE INC. | $4.82 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070125 | CMS |
| Boston Scientific Corporation | $57.99 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092457236 | CMS |
| Eisai Inc. | $21.31 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110749574 | CMS |
| Eisai Inc. | $31.27 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110749576 | CMS |
| SK Life Science, Inc. | $33.36 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154116737 | CMS |
| SK Life Science, Inc. | $30.77 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154116745 | CMS |
| SK Life Science, Inc. | $31.20 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154116835 | CMS |
| SK Life Science, Inc. | $28.42 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154116867 | CMS |
| SK Life Science, Inc. | $33.56 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154116881 | CMS |
| SK Life Science, Inc. | $32.31 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154116887 | CMS |
| Sumitomo Pharma America, Inc. | $27.12 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148918164 | CMS |
| Sumitomo Pharma America, Inc. | $27.39 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148918166 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.59 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151516685 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.